BRIEF published on 06/18/2025 at 07:05, 11 months 24 days ago PHAXIAM Therapeutics suspends trading of its shares Euronext Paris Innovative Treatments PHAXIAM Suspension Of Quotation Delisting Securities
PRESS RELEASE published on 06/18/2025 at 07:00, 11 months 24 days ago Inside Information / Other news releases PHAXIAM Therapeutics suspends trading shares for delisting on Euronext Paris market. No reimbursement to shareholders. Company focuses on innovative phage-based treatments for resistant bacterial infections Trading Delisting Suspension PHAXIAM Therapeutics Phage-based Treatments
BRIEF published on 06/05/2025 at 07:05, 1 year ago PHAXIAM Therapeutics Facing Potential Liquidation Amid Court Hearing Postponement Biopharmaceuticals Judicial Liquidation Court Hearing PHAXIAM Therapeutics Euronext Delisting
PRESS RELEASE published on 06/05/2025 at 07:00, 1 year ago Inside Information / Other news releases PHAXIAM Therapeutics announces new postponement of Offer Review Hearing by Lyon Commercial Court to June 11, 2025. Company to request delisting from Euronext Euronext Delisting Postponement PHAXIAM Therapeutics Lyon Commercial Court
BRIEF published on 03/14/2025 at 17:50, 1 year 2 months ago PHAXIAM Therapeutics seeks buyer in receivership Euronext Paris PHAXIAM Therapeutics Judicial Recovery Looking For A Buyer Extension Of Procedure
PRESS RELEASE published on 03/14/2025 at 17:45, 1 year 2 months ago Inside Information / Other news releases PHAXIAM Therapeutics launches bidding process to find buyers amid receivership, trading of shares to resume on Euronext Paris. Court decides on procedure extension on April 30, 2025 Euronext Paris Receivership PHAXIAM Therapeutics Court Decision Bidding Process
BRIEF published on 03/06/2025 at 18:01, 1 year 3 months ago PHAXIAM Therapeutics Enters Receivership and Delays Financial Results Trading Suspension Financial Results Delay PHAXIAM Receivership Biotech Challenges Court-appointed Administrator
PRESS RELEASE published on 03/06/2025 at 17:56, 1 year 3 months ago Inside Information / Other news releases PHAXIAM Therapeutics announces the opening of a receivership procedure and postponement of its 2024 financial results publication. The company continues operations under observation period Financial Results Biopharmaceutical Company PHAXIAM Therapeutics Receivership Procedure Phage-based Treatments
BRIEF published on 03/06/2025 at 11:45, 1 year 3 months ago Suspension of the Listing of PHAXIAM Therapeutics Euronext Paris Biopharmaceutical PHAXIAM Therapeutics Suspension Of Quotation Resistant Infections
BRIEF published on 12/30/2024 at 17:50, 1 year 5 months ago PHAXIAM Therapeutics: Promising results from the PhagoDAIR pilot study Infection Control PHAXIAM Therapeutics Phase II GLORIA PhagoDAIR Study Anti-S. Aureus Phages
Published on 06/12/2026 at 08:05, 41 minutes ago Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
Published on 06/12/2026 at 08:00, 46 minutes ago Caledonia Mining Corporation Plc: Utilisation of the Block Admission in Respect of ATM Sales Agreement
Published on 06/12/2026 at 00:00, 8 hours 46 minutes ago Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
Published on 06/12/2026 at 00:00, 8 hours 46 minutes ago UraniumX Closes Oversubscribed Flow-Through Private Placement
Published on 06/12/2026 at 08:00, 46 minutes ago EQS-Adhoc: Tirlán Co-operative Society Limited: RESULT OF SECONDARY SHARE SALE
Published on 06/12/2026 at 07:45, 1 hour 1 minute ago Hisense RGB-themed pop-up event lights up the new landmark of FIFA World Cup 2026™
Published on 06/12/2026 at 07:30, 1 hour 16 minutes ago Steyr Motors conquers the UGV market – engine technology powers autonomous ground vehicles
Published on 06/12/2026 at 07:30, 1 hour 16 minutes ago Acclaim, inspiration and wonder as international winners of BRICK AWARD 26 receive plaudits in Vienna
Published on 06/12/2026 at 07:29, 1 hour 17 minutes ago Annual General Meeting of Mister Spex SE approves all management proposals by a clear majority
Published on 06/11/2026 at 17:45, 15 hours 1 minute ago BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
Published on 06/11/2026 at 08:45, 1 day ago Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts
Published on 06/10/2026 at 18:29, 1 day 14 hours ago ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026
